0001127602-16-054416.txt : 20160602 0001127602-16-054416.hdr.sgml : 20160602 20160602145648 ACCESSION NUMBER: 0001127602-16-054416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160531 FILED AS OF DATE: 20160602 DATE AS OF CHANGE: 20160602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioScrip, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 BROADWAY STREET 2: SUITE 950 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 720 697 5200 MAIL ADDRESS: STREET 1: 1600 BROADWAY STREET 2: SUITE 950 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLUBIAK MYRON Z CENTRAL INDEX KEY: 0001199080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28740 FILM NUMBER: 161692234 MAIL ADDRESS: STREET 1: C/O CITIUS PHARMACEUTICALS, INC. STREET 2: 63 GREAT ROAD CITY: MAYNARD STATE: MA ZIP: 01754 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-05-31 1 0001014739 BioScrip, Inc. BIOS 0001199080 HOLUBIAK MYRON Z C/O BIOSCRIP, INC. 1600 BROADWAY, SUITE 950 DENVER CO 80202 1 Common Stock, $.0001 Par Value 2016-05-31 4 M 0 10000 0 A 50000 D Common Stock, $.0001 Par Value 2016-05-31 4 D 0 10000 2.70 D 40000 D Phantom Stock 2016-05-31 4 M 0 10000 D Common Stock, $.0001 Par Value 10000 0 D Under the terms of the market-based cash award, as publicly filed, each share of "phantom stock" is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Each share of "phantom stock" granted pursuant to the market-based cash award was entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, which was $2.70 based on the closing market price of the Common Stock on May 31, 2016. The cash settlement of the market-based cash award is reported solely for purposes of Form 4 as the deemed disposition of the market-based cash award and a deemed simultaneous acquisition and disposition of 10,000 shares of Common Stock. The market-based cash award vested on May 31, 2016, the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, because the reporting person served as a director of the Issuer as of such date. If unvested on the vesting date, the market-based cash award would have expired on May 31, 2016. /s/ Myron Z. Holubiak 2016-06-02